期刊文献+

从特发性间质性肺炎分型演变看临床认识更新 被引量:5

Changes in clinical knowledge updates from the evolution of idiopathic interstitial pneumonia classification
原文传递
导出
摘要 特发性间质性肺炎是指一组原因不明的间质性肺疾病,对于其分类的认识经历了一个逐渐演变的过程,除了新的临床病理类型不断发现外,分类方法从单纯病理分类向临床分类过渡,诊断方法从单纯依靠病理学诊断逐步转向临床-病理-影像多学科诊断,这一演变过程反映了人们对特发性间质性肺炎的认识在不断深入。 Idiopathic interstitial pneumonias (IIPs) are a group of interstitial lung disease with unknown causes and its classi- fication experienced a gradually evolving process. In addition to describing new clinical histologic entities, the methods of classification move from the simply pathological patterns to the clinical algorithm based on observed disease behavior, the di- agnostic criteria gradually switch from purely pathological diagnosis to the clinical, pathological and radiologic multidiscipli- nary discussion. This evolution reflects our deepening understanding of idiopathic interstitial pneumonias.
作者 徐作军
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第8期737-739,共3页 Chinese Journal of Practical Internal Medicine
关键词 特发性间质性肺炎 idiopathic interstitial pneumonia
  • 相关文献

参考文献5

二级参考文献58

  • 1姚卫民,赖克方,罗远明,刘春丽,陈如冲,罗炜,钟南山.多次食管酸灌注对豚鼠气道阻力和气道反应性的影响及其机制探讨[J].南方医科大学学报,2009,29(7):1313-1316. 被引量:5
  • 2高晓方,崔社怀.干扰素γ对实验大鼠肺纤维化的治疗作用及机制的初步研究[J].第三军医大学学报,2005,27(2):143-145. 被引量:21
  • 3ATS/ERS. International multidisciplinary consensus classification of the Idiopathic interstitial pneumonias [ J ]. Am J Respir Crit Care Med, 2002,165 ( 2 ) :277
  • 4Meltzer EB,Noble PW. Idiopathic pulmonary fibrosis[ J ]. Orphanet J Rare Dis,2008,3:8
  • 5Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel[ J ]. Chest,2005,128 ( 5 Suppl 1 ) :526S
  • 6Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis:frequency and clinical features [ J ]. Eur Respir J,2006 (27) : 143 - 150.
  • 7American Thoracic Society/European Respiratory Society International Muhidisciplinary Classification of the idiopathic interstitial pneumonias [ J ]. Am J Respir Crit Care Med,2002 ( 165 ) : 277 - 304.
  • 8Raghu G. Idiopathic pulmonary fibrosis:treatment options in pursuit of evidence-based approaches [ J ]. Eur Respir J,2006 ( 28 ) :463 - 465.
  • 9Mapel DW, Samet .IM, Coultas DB. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future [ J ]. Chest, 1996 (4) : 1 058 - 1 067.
  • 10Selman M ,Thannickal V J, Pardo A, et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches [J]. Drugs,2004(4) :405 -430.

共引文献43

同被引文献49

  • 1宫帅,刘跃建,杨勇.从指南看特发性肺纤维化治疗药物的选择[J].世界临床药物,2013,34(1):17-20. 被引量:4
  • 2陈晶晶,张念志.间质性肺病患者的护理与自我保健[J].求医问药(下半月),2013(2):134-135. 被引量:1
  • 3吕长俊,张祥盛.特发性间质性肺炎的分类[J].山东医药,2005,45(4):64-64. 被引量:1
  • 4张德平,侯杰.对特发性肺纤维化急性加重的新认识[J].中华结核和呼吸杂志,2007,30(4):298-300. 被引量:11
  • 5Fukuhara A,Tanino Y,Ishii T,et al.Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation[J].Eur Respir J,2013,42(6);1757-1759.
  • 6Walne AJ,Dokal I.Dyskeratosis Congenita:a historical perspective[J].Mech Ageing Dev,2008,129(1-2):48-59.
  • 7Walne AJ,Vulliamy Tf Beswick R,et al.TINF2 mutations result in very short telomeres:analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes [J].Blood,2008,112(9):3594-3600.
  • 8Alter BP,Giri N,Savage SA,et al.Cancer in dyskeratosis congenita[J].Blood,2009,113(26):6549-6557.
  • 9Dokal I,Vulliamy T,Mason P,et al.Clinical utility gene card for:dyskeratosis congenita[J].Eur J Hum Genet,2011,19(11).
  • 10Fernandez GM,Teruya-Feldstein J.The diagnosis and treatment of dyskeratosis congenita:a review[J].J Blood Med,2014,5:157-167.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部